Lamictal is an anti-epileptic medicine manufactured by GlaxoSmithKline, the UK's largest pharmaceutical company and one of the biggest pharmaceutical companies in the world. Containing the drug lamotrigine, Lamictal is an anticonvulsant drug which is used to treat not only epilepsy but also bipolar disorder. In addition to its anticonvulsant effects, Lamictal also acts as a mood stabiliser and was indeed the first drug approved in the USA for this purpose since lithium almost 30 years previously. Classed as a phenyltriazine, Lamictal enhances the action of GABA, a neurochemical involved in relaxation and also shows the ability to suppress the excitatory neurotransmitters glutamata and aspartate.
Lamictal is chemically distinct from other anticonvulsants and is one the World Health Organisation's list of essential medicines shown to be both highly effective and to demonstrate excellent safety. It blocks the signals in the brain that would normally cause a seizure making a substantial difference to patient welfare.
Lamictal is indicated in patients suffering from specific types of epilepsy and bipolar disorder and is licensed to treat both men and women, and both adults and children. In addition, Lamictal is sometimes used to treat neuropathic pain and migraines as well as used off-label in some other psychiatric disorders.
Lamictal should be taken exactly as prescribed by your doctor. In general, it is taken once or twice a day and can be taken with our without food. It is important that when taking them patients take them whole and do not crush or chew the tablets. Always refer to product literature.